Eyestem Research Pvt Ltd.
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.eyestem.com
Safety & Efficacy of Eyecyte-RPEâ„¢ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.
Phase 1
Recruiting
- Conditions
- Geographic AtrophyMacular DegenerationAge-Related Macular DegenerationEye DiseasesRetinal Disease
- Interventions
- Drug: Eyecyte-RPEâ„¢
- First Posted Date
- 2024-05-01
- Last Posted Date
- 2024-06-05
- Lead Sponsor
- Eyestem Research Pvt. Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT06394232
- Locations
- 🇮🇳
L V Prasad Eye Institute, Hyderabad, Telangana, India
🇮🇳Shri Ganapati Netralaya, Jalna, Maharashtra, India
🇮🇳All India Institute of Medical Sciences, Delhi, New Delhi, India
© Copyright 2025. All Rights Reserved by MedPath